1. Home
  2. SOTK vs INKT Comparison

SOTK vs INKT Comparison

Compare SOTK & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono-Tek Corporation

SOTK

Sono-Tek Corporation

HOLD

Current Price

$4.08

Market Cap

68.8M

Sector

Technology

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$9.74

Market Cap

57.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOTK
INKT
Founded
1975
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.8M
57.6M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
SOTK
INKT
Price
$4.08
$9.74
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
28.9K
147.7K
Earning Date
01-13-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$20,504,381.00
N/A
Revenue This Year
$4.02
N/A
Revenue Next Year
$10.95
N/A
P/E Ratio
$51.69
N/A
Revenue Growth
4.08
N/A
52 Week Low
$3.23
$6.66
52 Week High
$5.15
$76.00

Technical Indicators

Market Signals
Indicator
SOTK
INKT
Relative Strength Index (RSI) 49.37 39.91
Support Level $4.03 $6.80
Resistance Level $4.18 $12.64
Average True Range (ATR) 0.20 0.71
MACD 0.00 -0.16
Stochastic Oscillator 49.29 7.28

Price Performance

Historical Comparison
SOTK
INKT

About SOTK Sono-Tek Corporation

Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: